What does CUSIP 71880W303 represent in this 13F holders report?

CUSIP 71880W303 is the security identifier for PHIO - PHIO PHARMACEUTICALS CORP - COM NEW used to aggregate holder disclosures.

How many institutions held PHIO - PHIO PHARMACEUTICALS CORP - COM NEW in Q2 2021?

15 institutional investors reported PHIO - PHIO PHARMACEUTICALS CORP - COM NEW for Q2 2021. Use the holders table for investor-level position and value details.

PHIO PHARMACEUTICALS CORP - COM NEW (PHIO)

CUSIP: 71880W303

Q2 2021 13F Holders as of 30 Jun 2021

Security type / class: Equity / COM NEW
Total 13F shares: 699,661
Total 13F value: $1,581,000
Share change: +199,051
Put/Call ratio: 16%
SEC-reported price per share: $2.26
Number of holders: 15
Value change: +$383,139
Number of buys: 11
Number of sells: 7

Security key

71880W303

Report period

Q2 2021

Institutions

Top holders

PHIO full security history Ownership snapshot Full 13F holder table Phio Pharmaceuticals Corp. SEC filings Phio Pharmaceuticals Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GSA CAPITAL PARTNERS LLP

Disclosed value leader

GSA CAPITAL PARTNERS LLP

Comparable rows

0/14

Latest evidence

31 Mar 2021

13F Highest disclosed value: $355,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

GSA CAPITAL PARTNERS LLP has the largest disclosed position value at $355K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GSA CAPITAL PARTNERS LLP's linked filing trail.

Disclosed position value Top 5

GSA CAPITAL PARTNERS LLP $355K

VANGUARD GROUP INC $329K

GEODE CAPITAL MANAGEMENT, LLC $234K

DIMENSIONAL FUND ADVISORS LP $93K

TWO SIGMA ADVISERS, LP $79K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GSA CAPITAL PARTNERS LLP	13F Company 13F	— denominator unverified	$355,000 132,333 shares	—	31 Mar 2021
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$329,000 122,697 shares	—	31 Mar 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$234,000 87,501 shares	—	31 Mar 2021
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	— denominator unverified	$93,000 34,808 shares	—	31 Mar 2021
TWO SIGMA ADVISERS, LP	13F Company 13F	— denominator unverified	$79,000 29,500 shares	—	31 Mar 2021
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$62,000 23,172 shares	—	31 Mar 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

699,661

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q2 2021 value	Value change	Value Chg %